The decision to cancel a preimplantation genetic diagnosis cycle
✍ Scribed by J. Santaló; M. Grossmann; C. Giménez; F. Marina; J. Egozcue; S. Marina; F. Vidal
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 52 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Research in the field of preimplantation genetic diagnosis (PGD) has concentrated on increasing the number of diseases diagnosed, different strategies for single cell analysis and improving efficiency and reliability. Of equal importance are clinical issues such as the demand for and cost of PGD. Th
Preimplantation genetic diagnosis (PGD) can be offered as an alternative to prenatal diagnosis (PND) to couples at risk of having a child with a genetic disease. The affected embryos are detected before implantation by fluorescent in situ hybridisation (FISH) for sexing (X-linked diseases) and chrom
Preimplantation genetic diagnosis (PGD) allows the selection of unaffected IVF embryos for transfer in couples that are at risk for transmitting genetic diseases. For monogenic diseases, polymerase chain reaction (PCR)-based diagnosis is usually performed on single blastomeres. In Greece, up to 10 p
Considerable differences in the regulatory oversight of preimplantation genetic diagnostic (PGD) services exist among countries, ranging from total bans on any embryo manipulation to the almost complete absence of any regulations or authority. A survey of centres offering PGD services revealed commo
A new form of genodermatosis resulting from mutations in the gene plakophilin 1 (PKP1) has recently been identified. The clinical features of a functional knockout of PKP1 are a combination of skin fragility and a form of hypohydrotic ectodermal dysplasia. We have developed a single cell polymerase